Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.45 |
| ▸ | RELA | Q04206 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 4/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17042383 | 0.92 | MEN1 (0.51) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL16698000 | 0.86 | PTGS2 (0.44) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL926427 | 0.82 | APP (0.52) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL12589721 | 0.81 | NR1H2 (0.42) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL22344857 | 0.80 | CPT1B (0.38) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL22356374 | 0.78 | THRB (0.43) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL11099340 | 0.76 | GRIA1 (0.43) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL11453774 | 0.76 | HDAC6 (0.37) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL11453631 | 0.76 | PTGS2 (0.43) | NPC1MEN1KMT2ARAB9ANFKB1 | |
| SCHEMBL8974883 | 0.75 | TSHR (0.53) | MEN1KMT2ALMNAMAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025022768-A1 | CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, AND CURED PRODUCT | 三菱瓦斯化学株式会社 | 2025-01-30 | — | — | WO | disclosed |
| WO-2025022769-A1 | CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, AND CURED PRODUCT | 三菱瓦斯化学株式会社 | 2025-01-30 | — | — | WO | disclosed |
| CN-111065628-B | Novel triazine derivative and photosensitive composition comprising the same | 株式会社特雷尔 | 2023-06-02 | — | — | CN | disclosed |
| US-11427551-B2 | Triazine derivative and photosensitive composition comprising same | TREEEL CO., LTD (KR) | 2022-08-30 | — | — | US | disclosed |
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TREEEL CO., LTD (KR) | 2020-08-20 | — | — | US | disclosed |
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TREEEL CO., LTD (KR) | 2020-08-20 | — | — | US | disclosed |
| EP-2913302-B1 | CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2019-04-10 | — | — | EP | disclosed |
| WO-2019054707-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | 주식회사 트리엘 | 2019-03-21 | — | — | WO | disclosed |
| US-9475761-B2 | Method for producing cyanogen-halide, cyanate ester compound and method for producing the same, and resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-10-25 | — | — | US | disclosed |
| US-20150299110-A1 | METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-10-22 | — | — | US | disclosed |
| EP-2913302-A1 | CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION | Mitsubishi Gas Chemical Company, Inc. (JP) | 2015-09-02 | — | — | EP | disclosed |
| CN-104755422-A | Method for producing cyanogen halide, cyanate ester compound and method for producing same, and resin composition | MITSUBISHI GAS CHEMICAL CO | 2015-07-01 | — | — | CN | disclosed |
| US-7956020-B2 | Reducing friction between two moving surfaces; oil additive mixture | FUJIFILM CORPORATION (JP) | 2011-06-07 | — | — | US | disclosed |
| US-7956020-B2 | Reducing friction between two moving surfaces; oil additive mixture | FUJIFILM CORPORATION (JP) | 2011-06-07 | — | — | US | disclosed |
| US-20080274920-A1 | Reducing friction between two moving surfaces; oil additive mixture | FUJIFILM CORPORATION (JP) | 2008-11-06 | — | — | US | disclosed |
| US-20080274920-A1 | Reducing friction between two moving surfaces; oil additive mixture | FUJIFILM CORPORATION (JP) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299110-A1 | METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION | MB, CBR3, CRYAA | NPC1 1856/4885MEN1 296/4885KMT2A 529/4885 |
| US-11427551-B2 | Triazine derivative and photosensitive composition comprising same | TYR, CRY2, CRY1 | NPC1 1631/4885MEN1 679/4885KMT2A 525/4885 |
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TYR, CRY2, CRY1 | NPC1 1765/4885MEN1 714/4885KMT2A 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.